EPTIS
BAM Logo

Thrombophilia screening

[Thrombophilie-Screening]

EPTIS Ringversuch Nr. 820420 | Letze Änderung 2021-01-18 | URL: https://www.eptis.bam.de/pts820420 https://www.eptis.bam.de/pts820420

Name des Anbieters
Name des Anbieters Reference Institute for Bioanalytics Reference Institute for Bioanalytics
Ansässig in Germany
Sprache(n) German and English
Anmerkungen In cooperation with the Dutch organization ECAT the Reference Institute for Bioanalytics provides special surveys for thrombophilia screening. The preparation of the survey material, what is in most cases native patient material, the mailing of samples and the evaluation is done by our colleagues from the Netherlands. Sample material: The samples will consist of lyophilized human plasma or serum with different volume (0,5 to 1 ml). Per analyte or set of analytes you will get one or two sample(s). Please note our deadline for the order and please use for the applications the special application form! We can not accept cancellations during the annual programme. The result submission is only possible via internet. This survey is not subject of the accreditated area of the RfB. The Reference Institute for Bioanalytics is part of the non-profit foundation “Stiftung für Pathobiochemie und Molekulare Diagnostik” and designs and organizes surveys for External Quality Assurance in Clinical Chemistry and Laboratory Medicine on their behalf and on nomination by the German Medical Association. From the order and the transmission of the results to the delivery of the evaluations and certificates, participation is fully implemented via our web portal. http://www.rfb.bio/
Klassifizierung
Produktgruppen Human test material
Prüfgebiete Medical analysis
Technische Einzelheiten
Prüfobjekt Prüfeigenschaft Prüfmethode
plasma or serum, lyophilized Thrombophilia module I -
Antithrombin activity and antigen, Protein C activity and antigen, Protein S activity and antigen -
Thrombophilia module II -
APC resistance -
Lupus Anticoagulant -
Von Willebrand Factor -
ADAMTS13 (activity and antigen) -
Factor XIII -
Fibrinolysis parameters -
Plasminogen, Antiplasmin, t-PA, PAI-1 -
Unfractionated Heparin Monitoring -
Low-Molecular Weight heparin Monitoring -
Factor VIII Inhibitor -
Thrombin generation test -
ADAMTS13 (Antibodies) -
Factor IX Inhibitor -
HIT - immunological test -
Ringversuchsziele
Zielgruppe des Ringversuchs This PT is intended for medical laboratories.
Relevante Rechtsvorschriften oder Normen
Weitere Ziele
Teilnehmerzahl
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)
Die Durchführung des Ringversuchs ist in Auftrag gegeben durch
Kosten
Teilnahmegebühr This information can you see of www.rfb.bio
Regelmässig durchgeführt Ja (every quarter)
Der Ringversuch wird durchgeführt seit
Kontaktdaten des Anbieters
Anbieter Kontaktperson
Reference Institute for Bioanalytics
Friesdorfer Str. 153
53175 Bonn
Germany

Telefon: +49 228 926895 0
Fax: +49 228 926895 29
Web: http://www.rfb.bio http://www.rfb.bio
Dr. Anja Kessler
Telefon: +49 228 926895 0
Fax: +49 228 926895 29
E-Mail: info@dgkl-rfb.de info@dgkl-rfb.de
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5